Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network
Authors
Keywords
-
Journal
HPB
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-08-25
DOI
10.1016/j.hpb.2022.08.008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatic Artery Infusion Pump (HAIP) Therapy Versus Chemotherapy in the First-Line Setting for Patients with Unresectable Intrahepatic Cholangiocarcinoma
- (2021) Alexander J. Rossi et al. ANNALS OF SURGICAL ONCOLOGY
- Combined Primary Resection with Hepatic Artery Infusion Pump Implantation Is Safe for Unresectable Colorectal Liver Metastases
- (2021) Megan C. Turley et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases
- (2020) John M. Creasy et al. ANNALS OF SURGICAL ONCOLOGY
- Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study
- (2020) Hala Muaddi et al. JOURNAL OF SURGICAL ONCOLOGY
- Getting Chemotherapy Directly to the Liver: The Historical Evolution of Hepatic Artery Chemotherapy
- (2020) Roi Anteby et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Abrupt Discontinuation of the Codman Hepatic Artery Infusion Pump: Considerations in the Era of Precision Medicine
- (2019) Ryan J. Ellis et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial
- (2019) F. E. Buisman et al. BMC CANCER
- Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands
- (2019) Florian E. Buisman et al. ANNALS OF SURGICAL ONCOLOGY
- Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma
- (2019) Andrea Cercek et al. JAMA Oncology
- Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases
- (2018) Jeffery Chakedis et al. JOURNAL OF SURGICAL ONCOLOGY
- Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis
- (2017) Bas Groot Koerkamp et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential
- (2017) Linda M. Pak et al. JOURNAL OF SURGICAL ONCOLOGY
- Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case–Control Study
- (2016) Mashaal Dhir et al. ANNALS OF SURGICAL ONCOLOGY
- Robotic assisted placement of hepatic artery infusion pump is a safe and feasible approach
- (2016) Mashaal Dhir et al. JOURNAL OF SURGICAL ONCOLOGY
- Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution
- (2013) John B. Ammori et al. ANNALS OF SURGICAL ONCOLOGY
- Cause of Death from Liver Metastases in Colorectal Cancer
- (2013) Thomas S. Helling et al. ANNALS OF SURGICAL ONCOLOGY
- Phase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal Cancer
- (2011) Benedito A. Carneiro et al. Clinical Colorectal Cancer
- Bevacizumab Combined With Chemotherapy in the Second-Line Treatment of Metastatic Colorectal Cancer: Results from the Phase II BEVACOLOR Study
- (2011) Jaafar Bennouna et al. Clinical Colorectal Cancer
- Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results?
- (2011) Nancy E. Kemeny et al. ONCOLOGY
- Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma
- (2009) Nancy E. Kemeny et al. JOURNAL OF CLINICAL ONCOLOGY
- Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741
- (2008) Hanna K. Sanoff et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now